Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royal Queen Seeds is a leading European cannabis seed bank and genetic research company specializing in the development of high-quality cannabis strains. The company achieved a significant industry milestone by introducing the first true F1 hybrid cannabis seeds, which provide enhanced uniformity, stability, and yield compared to traditional strains. Their product portfolio includes feminized, autoflowering, and CBD-rich seeds tailored for both medical and recreational use. RQS operates several brick-and-mortar locations across Europe and maintains a robust global e-commerce presence. The company continues to invest in genetic innovation to optimize cannabinoid and terpene profiles for therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Royal Queen Seeds.